Today’s cancer therapies are tricky, costly, and slow to generate. But the combination of new computing and new organic technologies is main to a superior knowledge of the human immune process, with the intention of offering a superior course of cancer therapies.
Azeem Azhar speaks with Immunai co-founder and main technological innovation officer Luis Voloch about how AI is unlocking the tricks of the immune procedure and opening new avenues for novel cancer remedies.
They also explore:
- Why Luis and his co-founder, two machine understanding engineers, decided to start off a bio startup.
- How Immunai employs solitary-mobile genomics to map out the immune process.
- The trajectory of Immunai’s experiments from the lab to the affected person.
@Azeem
@exponentialview
@Immunaitech
Even more sources:
Scaling Artificial Biology (with Gingko’s Reshma Shetty), Exponential See Podcast, 2022
The Long run of Healthcare: Personalization and AI (with ZOE’s Jonathan Wolf), Exponential View Podcast, 2022
A transcript of this episode will be offered by April 13, 2022.
More Stories
Investing In A Developing Economy – A Possible Solution To Global Financial Crisis
The National Entrepreneurship Development
Buying Property in Malta